ENACARD
(enalapril maleate)

ENACARD is indicated for the treatment of mild, moderate or severe heart failure in dogs caused by mitral regurgitation or dilated cardiomyopathy, in combination with standard therapy. For improved tolerance and increased survival in dogs with mild, moderate or severe heart failure.

ENACARD addresses the primary health risks of heart disease in dogs by helping the heart work more efficiently, preventing fluid build-up in the lungs, and lowering blood pressure. This can help improve your dog’s ability to safely tolerate exercise.
Dogs treated with ENACARD show significant improvements that you can see and appreciate in 2 to 4 weeks. They cough less, eat more, and become more active. Dogs receiving ENACARD survive longer (92%) and have a better quality of life.

Key Features:

• Available in a range of dosages for easy administration
• Fast acting – dogs typically show visible improvement within 2-4 weeks
• Allows your dog return to a more active, involved lifestyle

Presentation:

28 x 1 mg Tablets (Green)
28 x 2.5 mg Tablets (Blue)
28 x 5 mg Tablets (Pink)                             
28 x 10 mg Tablets (Yellow)
28 x 20 mg Tablets (White)

Click here for information about Heart Disease
Click here to view Product Label